Posted by Michael Wonder on 15 Oct 2021
Recommendations made between March 2021 and November 2021 PBAC meetings
15 October 2021 - Recommendations made by the PBAC between the March 2021 and November 2021 have been published.
The PBAC recommended the following medicines:
- Adrenaline (multiple brands) - restriction change
- Ribavirin (Ibavyr) - new strength
- Upadacitinib monohydrate (Rinvoq) - new indication
